Should You Invest in Metlife Inc (MET) Now?

Metlife Inc (NYSE: MET) has a higher price-to-earnings ratio of 22.26x compared to its average ratio, The 36-month beta value for MET is at 1.03. Analysts have varying views on the stock, with 6 analysts rating it as a “buy,” 3 rating it as “overweight,” 6 as “hold,” and 0 as “sell.”

The public float for MET is 584.87M, and currently, shorts hold a 1.29% of that float. The average trading volume for MET on October 01, 2024 was 3.37M shares.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

MET) stock’s latest price update

The stock of Metlife Inc (NYSE: MET) has decreased by 0.00 when compared to last closing price of 82.48. Despite this, the company has experienced a 1.25% gain in its stock price over the last five trading sessions. seekingalpha.com reported 2024-09-27 that The ‘Undercovered’ Dozen series highlights 12 undercovered stocks to provide another source for investment ideas and to encourage community discussion. Mosaic Company, a leading phosphate fertilizer producer, is a high-quality investment with irreplaceable assets, offering strong potential when commodity prices are low, according to Macrotips Trading. K92 Mining aims to increase gold production significantly by 2026, with exploration results indicating further growth potential, which Peter Arendas argues makes it a strong buy.

MET’s Market Performance

Metlife Inc (MET) has seen a 1.25% rise in stock performance for the week, with a 7.49% gain in the past month and a 18.03% surge in the past quarter. The volatility ratio for the week is 1.40%, and the volatility levels for the past 30 days are at 1.79% for MET. The simple moving average for the last 20 days is 5.51% for MET stock, with a simple moving average of 15.31% for the last 200 days.

Analysts’ Opinion of MET

Many brokerage firms have already submitted their reports for MET stocks, with Barclays repeating the rating for MET by listing it as a “Overweight.” The predicted price for MET in the upcoming period, according to Barclays is $91 based on the research report published on September 05, 2024 of the current year 2024.

Goldman, on the other hand, stated in their research note that they expect to see MET reach a price target of $80. The rating they have provided for MET stocks is “Buy” according to the report published on January 08th, 2024.

Barclays gave a rating of “Overweight” to MET, setting the target price at $71 in the report published on November 17th of the previous year.

MET Trading at 9.67% from the 50-Day Moving Average

After a stumble in the market that brought MET to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -0.61% of loss for the given period.

Volatility was left at 1.79%, however, over the last 30 days, the volatility rate increased by 1.40%, as shares surge +6.45% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +10.30% upper at present.

During the last 5 trading sessions, MET rose by +1.25%, which changed the moving average for the period of 200-days by +26.50% in comparison to the 20-day moving average, which settled at $78.42. In addition, Metlife Inc saw 24.72% in overturn over a single year, with a tendency to cut further gains.

Insider Trading

Reports are indicating that there were more than several insider trading activities at MET starting from Separate Account 149, who proposed sale 27 shares at the price of $81.09 back on Sep 20 ’24. After this action, Separate Account 149 now owns shares of Metlife Inc, valued at $2,189 using the latest closing price.

MetLife Separate Account SPI, the Affiliate of Metlife Inc, proposed sale 370 shares at $81.09 during a trade that took place back on Sep 20 ’24, which means that MetLife Separate Account SPI is holding shares at $30,003 based on the most recent closing price.

Stock Fundamentals for MET

Current profitability levels for the company are sitting at:

  • 0.04 for the present operating margin
  • 1.0 for the gross margin

The net margin for Metlife Inc stands at 0.04. The total capital return value is set at 0.0. Equity return is now at value 10.12, with 0.43 for asset returns.

Based on Metlife Inc (MET), the company’s capital structure generated 0.41 points at debt to capital in total, while cash flow to debt ratio is standing at 0.77. The debt to equity ratio resting at 0.69. The interest coverage ratio of the stock is 2.81.

Currently, EBITDA for the company is 2.36 billion with net debt to EBITDA at -0.63. When we switch over and look at the enterprise to sales, we see a ratio of 0.81. The receivables turnover for the company is 2.14for trailing twelve months and the total asset turnover is 0.1. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.97.

Conclusion

In conclusion, Metlife Inc (MET) has had a better performance lately. Opinion on the stock among analysts is mixed, with some giving it a “buy” rating and others a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.

Related Posts